FMO5 and metabolic syndrome: Also, it has been reported recently that phagocytic NADPH oxidase overactivity is involved in ROS and atherosclerosis in metabolic syndrome patients and that hyperinsulinemia likely contributes to ROS in metabolic syndrome patients through activation of NADPH oxidase [117].